TABLE 1.
Data | SGOA (n = 20) | SGS (n = 20) | P‐value |
---|---|---|---|
Female | 19 (95%) | 17 (85%) | .292 |
Male | 1 (5%) | 3 (15%) | |
Age | 35.95 ± 15.09 | 43.60 ± 13.01 | .094 |
BMI (kg/m2) | 22.23 ± 0.60 | 23.12 ± 0.62 | .3147 |
Fitzpatrick skin type | |||
Type 3 | 5 (25%) | 5 (25%) | 1.000 |
Type4 | 15 (75%) | 15 (75%) | |
Risk group | |||
Low risk | 8 (40%) | 14 (70%) | .057 |
High risk | 12 (60%) | 6 (30%) | |
Type of surgery | |||
Benign breast mass excision | 12 (60%) | 14 (70%) | .783 |
Thyroidectomy | 1 (5%) | 1 (5%) | |
Subcutaneous nodule excision | 7 (35%) | 5 (25%) | |
Location | |||
Face | 5 (25%) | 2 (10%) | .373 |
Trunk | 12 (60%) | 14 (70%) | |
Extremities | 3 (15%) | 4 (20%) | |
POSAS‐observer | 14.05 ± 6.11 | 14.1 ± 4.54 | .9767 |
POSAS‐patient | 21.8 ± 8.83 | 21.1 ± 5.36 | .7635 |
Erythema index | 402.67 ± 80.79 | 419.84 ± 63.97 | .4610 |
Melanin index | 309.12 ± 146.51 | 310.67 ± 193.51 | .9772 |
R0 parameter (Cutometer) | 0.2025 ± 0.16 | 0.1776 ± 0.09 | .5504 |